COME ON MAN !!!!! $CAPR Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020 GlobeNewswire Capricor Therapeutics ,GlobeNewswire•September 23, 2020 --Final 12-Month Results from Phase II Trial to be Presented on October 1--